BryanAlexanderFiskMD

PubMed

• Sequence motifs of human her-2 protooncogene important for Peptide binding to hla-A2.
  Fisk B Chesak B Ioannides M Wharton J Ioannides C> ;Int J Oncol. 1994 Jul
• Mass-spectrometric analysis of naturally processed peptides recognized by ovarian tumor-associated CD8(+) CTL.
  Fisk B Dague B Seifert W Kudelka A Wharton J Murray J Ioannides C> ;Int J Oncol. 1997 Jan
• 1 citations
  N-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells.
  Satoko Matsueda, Hui Gao, Clayton L. Efferson, Naotake Tsuda, Satoshi Ishiyama, Yufeng Li, Maria G. Ioannides, Bryan Fisk, George E. Peoples, Constantin G. Ioannides> ;Anticancer Research. 2009 Jul 1
• 2 citations
  Outcomes following pneumococcal meningitis: room for improvement remains expansive.
  Bryan A. Fisk, William L. Jackson> ;Critical Care Medicine. 2006 Nov 1
• 24 citations
  Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Com...
  Agapito Castilleja, Darrick Carter, Clay L. Efferson, Nancy E. Ward, Kouichiro Kawano, B Fisk, Andrzej P. Kudelka, David M. Gershenson, James L. Murray, Catherine A. O...> ;Journal of Immunology. 2002 Oct 1
• HER-2/ neu peptide specificity in the recognition of HLA-A2 by natural killer cells
  Larry D. Anderson, J. Michael Hudson, Cherylyn A. Savary, B Fisk, David M. Gershenson, Constantin G. Ioannides> ;Cancer Immunology, Immunotherapy. 1999 Sep 17
• 41 citations
  Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.
  George E. Peoples, Brett W. Anderson, B Fisk, Andrzej P. Kudelka, J.T. Wharton, C. G. Ioannides> ;Annals of Surgical Oncology. 1998 Dec 1
• 12 citations
  Increased Sensitivity of Adriamycin-selected Tumor Lines to CTL-mediated Lysis Results in Enhanced Drug Sensitivity
  B Fisk, Constantin G. Ioannides> ;Cancer Research. 1998 Nov 1
• 26 citations
  Identification of Naturally Processed Human Ovarian Peptides Recognized by Tumor-associated CD8+ Cytotoxic T Lymphocytes
  B Fisk, Brett W. Anderson, K R Gravitt, Catherine A. O'Brian, Andrzej P. Kudelka, James L. Murray, J.T. Wharton, C. G. Ioannides> ;Cancer Research. 1997 Jan 1
• 35 citations
  Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides.
  B Fisk, Hudson Jm, John J. Kavanagh, J.T. Wharton, J. L. Murray, C. G. Ioannides, Andrzej P. Kudelka> ;Anticancer Research. 1997 Jan 1
• 445 citations
  Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.
  B Fisk, T L Blevins, J T Wharton, Constantin G. Ioannides> ;The Journal of Experimental Medicine. 1995 Jun 1
• 26 citations
  Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentati...
  B Fisk, Cherylyn A. Savary, Hudson Jm, Catherine A. O'Brian, James L. Murray, J.T. Wharton, C. G. Ioannides> ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1995 Jan 1
• 6 citations
  Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
  B Fisk, C. N. Flytzanes, M. S. Pollack, J T Wharton, C. G. Ioannides> ;Scandinavian Journal of Immunology. 1994 Dec 1
• 31 citations
  Oligopeptide Induction of a Cytotoxic T Lymphocyte Response to HER-2/Neu Proto-oncogene in Vitro
  B Fisk, Brad Chesak, Marilyn S. Pollack, J. Taylor Wharton, Constantin G. Ioannides> ;Cellular Immunology. 1994 Sep 1
• 15 citations
  Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line.
  B Fisk, C. G. Ioannides, S. Aggarwal, J T Wharton, Catherine A. O'Brian, N. Restifo, B. S. Glisson> ;Lymphokine and Cytokine Research. 1994 Apr 1
• Dissimilar tcr v-Beta frequencies in til from different sites of the same tumor.
  Fisk, B.,Flytzanis, C.,Tucker, S.,Ioannides, C.> ;Int. J. Oncol.. 1993 Dec 01
• 181 citations
  Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.
  Constantin G. Ioannides, B Fisk, Keith R. Jerome, Tatsuro Irimura, J T Wharton, Olivera J. Finn> ;Journal of Immunology. 1993 Oct 1
• 98 citations
  Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene.
  Constantin G. Ioannides, B Fisk, Dominic Fan, W E Biddison, J T Wharton, Catherine A. O'Brian> ;Cellular Immunology. 1993 Oct 1
• COMMON TCR-BETA CHAIN REARRANGEMENTS IN SHORT-TERM CULTURED LYMPHOCYTES INFILTRATING OVARIAN-TUMORS
  R Mayer, A Han, B Fisk, Cg Ioannides> ;International Journal of Oncology. 1993 May 1
• 27 citations
  Cytotoxic T‐Cell Clones Isolated from Ovarian Tumour Infiltrating Lymphocytes Recognize Common Determinants on Non‐Ovarian Tumour Clones
  C. G. Ioannides, B Fisk, M. S. Pollack, M. L. Frazier, J. Taylor Wharton, Ralph S. Freedman> ;Scandinavian Journal of Immunology. 1993 Apr 1
• 10 citations
  Induction of interleukin-2 receptor by tumor necrosis factor α on cultured ovarian tumor-associated lymphocytes
  Constantin G. Ioannides, B Fisk, Barbara Tomasovic, Raj K. Pandita, Bharat B. Aggarwal, Ralph S. Freedman> ;Cancer Immunology, Immunotherapy. 1992 Jan 1
• 14 citations
  Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
  Constantin G. Ioannides, S Rashed, B Fisk, Fan D, Itoh K, Freedman Rs> ;Lymphokine and Cytokine Research. 1991 Aug 1
• Join now to see all